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capacity. Consequently, in the infected individual, the virus circulates as a complex viral quasispecies [3] whose composition is subject to continuous changes due to competitive selection [4] and interactions among variants of with different levels of fitness [5] . The calculated average rate of fixation of mutations has consistently been found to range between 1.1 and 1.5 × 10 3 mutations per site and per year [6, 7] . The rate of fixation of mutations is not evenly distributed throughout the genome, which has highly variable regions within the envelope coding genes and well conserved regions, such as the 5' untranslated region (5'UTR). The practical consequence of the high conservation at 5'UTR for HCV genotyping is that this region contains insufficient variation to solve HCV classification at the level of viral subtypes [8] . Furthermore, genotype 6 variants other than 6a and 6b show 5'UTR sequences identical or similar to those of type 1 and, therefore, cannot be differentiated [9] [10] [11] . It has been reported that sequence analysis of the highly conserved region in NS5B known as the "Okamoto region" (nt 8282 to 8610 in the H77 reference genome) [8] provides the best concordance with the full length genome phylogeny for precise genotype identification. The same primers can amplify genotypes 1 to 5, and they are less efficient for genotype 6 isolates, but they facilitate analysis and classification of the amplified sequences [11] . The prevalence of HCV infection in Argentina has been reported at 1.5% when all age groups are considered, and up to 2.0% to 2.5% in adults [12] , a rate in keeping with the value reported by the Argentinian Consensus on Hepatitis C (approximately 2%) in 2007. A higher prevalence (4.9%-5.7%) has been described in small rural communities [13, 14] . HCV genotype distribution in Argentina in groups at risk of HCV infection (e.g., transfusion patients, hemodialysis patients, intravenous drug users, healthcare workers) has been reported at 53.5% for genotype 1, 23% for genotype 2 (mainly by subtype 2c [HCV-2c]), 8.6% for genotype 3, and 14.8% for mixed infections [15] . Similar results have been reported in studies on sequences deposited in GenBank (GB) and analyses by the Los Alamos database http: //hcv.lanl.gov, with few genotype distribution changes (79.5% for genotype 1, 13.9% for genotype 2, 3.9% for genotype 3, 2.4% for genotype 4), but with some differences depending on the HCV subgroup at risk studied [16] [17] [18] . Phylogenetic characterization of genotype 4 isolates from Argentina has traced an independent origin of the three sequences studied [17] . Interestingly, HCV-2c was the most prevalent subtype (58%) in the city of Córdoba (Central geographical region of the country), followed by HCV-1b (33%), and to a lesser extent by HCV-1a (11%), HCV-3a (3%) and HCV-4a (3%) [19, 20] . Here, we report an unexpectedly low prevalence of HCV infection (0.32%) as measured by anti-HCV antibodies detected by using both a second generation enzyme immune assay (EIA) and a confirmatory immunoblotting, and HCV RNA detected by reverse transcription -nested polymerase chain reaction (RT-nested PCR) 2 September 7, 2013|Volume 19|Issue 33| WJG|www.wjgnet.com del Pino N et al . Molecular epidemiology in Argentina distributed as follows: 1a (25%), 1b (25%), 2c (25%), 3a (5%), and 2j (5%). Two isolates ascribed either to genotype 1 (5%) or to genotype 3 (5%) by 5'UTR phylogenetic analysis could not be subtyped. Subtype 1a sequences comprised a highly homogeneous population and clustered with United States sequences. Genotype 1b sequences represented a heterogeneous population, suggesting that this genotype might have been introduced from different sources. Most subtype 2c sequences clustered close to the 2c reported from Italy and Southern France.
CONCLUSION: HCV has a low prevalence of 0.32% in the studied general population of Argentina. The pattern of HCV introduction and transmission in Argentina appears to be a consequence of multiple events and different for each subtype.
INTRODUCTION
The analysis of extensive sets of sequences from hepatitis C virus (HCV) isolates throughout the world has revealed the existence of six major genetic groups or genotypes (named 1 to 6), and a large number of subtypes within these groups (designated a, b, c, etc.) [1] . Overall sequence divergence ranges from 31% to 33% among genotypes and from 20% to 25% among subtypes [1, 2] ; in a single patient, cloned E1/E2 sequences may differ by up to 10%. The reason for this great variation is a high mutation rate and high level of viral replication through an error prone RNA polymerase without proofreading targetting the 5'UTR HCV RNA in a cohort of random Argentinian volunteers. The genotypes detected and the putative origin of the HCV sequences are discussed based based on both their phylogenetic clustering and on such clustering relative to other Argentinian and worldwide derived sequences deposited in GB, in an attempt to trace how HCV could have been introduced in the local community here represented by the cohort studied.
MATERIALS AND METHODS
Throughout the 2000-2007 period, a total of 6251 serum samples were collected from healthy volunteers from 12 Argentinian provinces, as well as from the Ciudad Autónoma de Buenos Aires (C.A.B.A. -the capital city of the country) as follows: Buenos Aires province and C.A.B.A., n = 1461; Catamarca, n = 648; Córdoba, n = 1061; Chaco, n = 353; Chubut, n = 172; Entre Ríos, n = 474; Jujuy, n = 176; Río Negro, n = 329; Salta, n = 561; San Luis, n = 195; Santiago del Estero, n = 375; and Tucumán, n = 446 (Table 1) .
Subjects included in this study [n = 6251; 2738 men; mean ± SE, 37.5 ± 0.2 years; mean ± SD = 37.5 ± 12.7; median age = 35 years (range 10-70 years)] were recruited as volunteers from the general population, local schools, and police stations, after being informed about the aim of the survey. All parents or legal guardians of individuals younger than 18 years provided informed written consent for participation. The corresponding written permission from all municipal authorities was obtained from each city or town where subjects were to be included.
Serological studies
The presence of anti-HCV antibodies was determined by using a second generation EIA test according to the manufacturer's recommendations (Abbott Diagnostics, North Chicago, IL, United States). Samples were further analyzed with a second generation recombinant immunoblot assay (RIBA 2.0: Chiron Corporation, Emeryville, CA, United States).
HCV-RNA detection and genotyping
Samples with serologically detectable anti-HCV antibodies were subjected to either RT-nested or RT-hemi-nested PCR amplification (see below). The 5'UTR region was used for RNA detection and initial genotype classification. The NS5B polymerase region, encompassing nt 8262-8610, was used for subtyping.
RNA extraction
RNA was extracted from 140 L of serum by using the QIAamp Viral RNA Mini Kit (Qiagen Hilden, Germany). The measures to prevent contamination suggested by Kwok and Higuchi were strictly applied [21] .
5'UTR RT-nested PCR amplification and sequencing
The 5'UTR RT-nested PCR was performed as follows. Five microliters of the product were used for nested PCR, by using internal primers the internal primers, K80 5' AGCGTCTAGCCATGGCGT3' and K78 5'CACTC-GCAAGCACCCTATCAGGCAGT3'. The nested PCR mix consisted of 1 × Pfu turbo buffer, 10 mmol/L of each dNTP, 20 pmol of internal primers, and 2.5 U of Pfu turbo DNA polymerase in a final volume of 100 L. After a single denaturation step of 2 min at 95 ℃, we carried out 30 cycles of 30 s at 95 ℃, 30 s at 60 ℃, and 2 min at 72 ℃, and then, a final single step of 10 min at 72 ℃. The amplified products of 240 nucleotides length were analyzed by lectrophoresis onto 2% agarose gels stained with ethidium bromide. PCR products were purified by using the QIAquick PCR purification kit for direct sequencing on an Abi Prism 310 Genetic analyser (Applied Biosystems).
NS5B RT-heminested-PCR amplification and sequencing
Extracted RNA was reverse transcribed using the de- Data are expressed as mean ± SE (SD, median). a P < 0.05, b P < 0.01, regarding the gender distribution (male/female ratio) within the whole population studied; d P < 0.01 regarding the mean age ± SD from the whole population studied. C.A.B.A.: Ciudad Autónoma de Buenos Aires, the national capital city.
our sequences grouped as a population, the closest GB sequences as another, and other Argentine sequences as the third one. Pairwise distances were calculated by using the MEGA3.1 program.
Statistical analysis
They were performed by using either the GraphPath Prism (version 5.0 for Windows) or the SigmaStat software. The non-paired Student's t test was used to analyze the statistical differences between the Mean age ± SD of the whole population of the country regarding those values recorded from each Province (therefore, examining a data set from two groups), as well as for such comparison with previous studies. When such study was performed among three or more groups, the one-way analysis of variance (ANOVA) was applied. Pairwise distances were statistically compared by using the  2 test with Yates' correction (SigmaStat software). P values lower than 0.05 were considered statistically significant.
RESULTS

HCV prevalence in the general population of Argentina
A total of 6251 serum samples from a cohort of random volunteers was studied. Initially, 25 samples (0.40%) tested anti-HCV antibody positive as determined by EIA. However, 5 of the 25 samples failed to exhibit specific anti-HCV antibodies by immunoblotting analysis and also tested negative by RT-nested PCR to detect HCV RNA; hence, they were discarded for further studies.
HCV RNA was detected in serum samples from 7 out of 12 provinces. The prevalence of ongoing HCV infection as determined by RT-nested PCR from 12 of 23 provinces of Argentina, representing 73% of the country's total population, was 0.32%. The highest prevalence was detected in Buenos Aires province (0.62%; 9/1461), a geographical area inhabited by 40.52% of the total population of Argentina. In the remaining provinces studied, the prevalence ranged from 0% in Chaco, Chubut, Entre Ríos, Jujuy, and San Luis, to up to 0.53% in Santiago del Estero. Intermediate values were observed in Salta (0.18%) and Córdoba (0.19%), Río Negro (0.30%), as well as in Catamarca (0.46%) and Tucumán (0.45%).
Genotype 1 was the most prevalent, accounting for 55% (11/20) of infected individuals, 25% were subtype 1a (5/20) and 25% subtype 1b (5/20). The second in prevalence was genotype 2 accounting for 35% (7/20) ; most sequences were ascribed to subtype 2c (n = 5), except one that clustered much closer to subtype 2j reference sequences. Lastly, genotype 3 accounted for the remaining 10% (2/20; Table 2 ). One genotype 1, one genotype 2 , as well as one genotype 3 isolates (according to their initial 5'UTR genotype assignment) were excluded from further analysis because of their respective NS5B RT-heminested PCR amplification failure. 
Phylogenetic analysis and genetic divergence
Genotyping and subtyping. GB sequences
A GB query to Nucleotide collection (nr/nt), using the Megablast programme (http://www.ncbi.nlm.nih.gov/ blast/Blast.cgi) was performed for each of the NS5B sequences obtained in this study. The 100 GB sequences with the highest sequence similarity to each of our samples were selected. A tree was constructed by using either the Neighbor-joining or Fast Minimum Evolution algorithm from a given matrix of distances using the Jukes-Cantor method to calculate the distances. For every query, we obtained a tree that situates each sequence with the most closely related reference from the GB. The most similar sequences were downloaded for further analysis, the genotype was assigned, and a putative origin of local isolates was inferred. GB was accessed to download already published sequences of Argentine origin by searching with the words "HCV" and "Argentina" on the website: http://www.ncbi.nlm.nih.gov/sites/gquery. Published sequences obtained by several authors [15, 17, 22, 23] were downloaded in Fasta format, and their length was then adjusted using the GeneDoc program [24] .
Phylogenetic analysis
Nucleotide sequences were resized by using GeneDoc and aligned by the CLUSTALW program [25] . Sequence similarity with other sequences from Argentina and with other GB sequences was ascertained by both distance and parsimony methods. Statistical support for each node in the trees drawn by both methods was obtained by performing 100 or 1000 bootstrap replicates of the original nucleotide sequence alignment. Phylogenetic analysis was carried out with the PHYLIP package [26] . Trees were drawn by using the Treeview program, v. 1.6.5 [27] .
Genetic divergence analysis
Genetic divergences were calculated by using the DNASP program (version 3.53) [28] in three populations:
performed by using the five HCV-1a, five HCV-1b, and five HCV-2c sequences. However, divergence could not be ruled out with those genotypes encompassing one single representative sequence (as occurred with 2j and 3a). As expected, local NS5B sequences clustered together with their corresponding GB references ( Figure   1 ), but the profile differed depending on the genotype. All of our HCV-1a Argentinian sequences clustered together with strong bootstrap support (92%; Figure 2A ) and exhibited a low genetic divergence (0.034; Table 3 ). Furthermore, genetic divergence was not statistically different in comparison with other Argentinian sequences deposited in GB or with the closest non-Argentinian GB deposited sequences included in the study, suggesting a putative common source of infection/transmission.
In the case of Argentinian HCV-1b, we observed two clusters with very low bootstrapping support (19%-25%), and one sequence distantly located regarding such clusters ( Figure 2B ). Genetic divergence was higher (0.082) than that observed among GB deposited Argentinian 1b sequences but the differences were not statistically significant. Similarly, HCV-2c sequences were intermingled along the tree with no particular clustering ( Figure 2C ) and showed a high genetic divergence (0.087). Phylogenetic analysis of Argentinian HCV-1b and HCV-2c sequences suggested a different origin of infection/transmission when compared with HCV-1a sequences.
Origin of closest GB sequences
The closest GB sequences obtained by distance (UPGMA and NJ) and parsimony methods (DNAPARS) are represented in Table 4 (trees not shown). The geographic localization of the closest GB sequences is represented in Figure 3 .
All local HCV-1a sequences grouped with GB United States sequences (St. Louis, Boston, or New York areas). The results suggest a narrow source of infection and not a multifocal event, and are consistent with the low degree of divergence found in the Argentine general population, despite the fact that the subjects studied resided in three different provinces (Buenos Aires, Córdoba, and Río Negro), and from whom serum sampling was performed, several hundred of kilometers apart from each other.
HCV-1b sequences grouped with those from all over the world, including Europe (Spain, Russia), Asia (China), Africa (Madagascar, Tunisia) and North America (United States), and represented a heterogeneous population (Table 3) . DQ220919  AY894529  P237  EU155304  533655  533771  DQ508481  DQ508479  DQ508484  DQ249499  DQ249500  EF608896  DQ249501  P899  EU155224  AY172648  AY172645  AY172646  AJ132997  AF506602  AY835061  AY682461  AY683105  DQ345626  P819  AY172641  DQ345627  532920  EU155272   995   454  114   673  890  629   996   104   111  419  998   12   256   50   16   211   244  617   3   130   117  49   18   238   EU155310  EU155290  EU155273  DQ889300  533511  DQ889282  T299  AY172640  DQ889296  P606  DQ313467  DQ313464  DQ313466  DQ313465  T294  AY682775  AY683103  AY682755  AY683093  DQ313468  DQ889318   999 EU155291  EU155343  AF011753  M62383  AF009606  AF011751  AF011752  AF177037  AF177038  AF177040  AF177039   15  56  19  21  21  23  25  26  29  AY683125  AY682782  DQ889291  EU155244  EU234065  DQ838739  EU155287  AY682758  AY683107  AY683101  DQ889277  EU155298  DQ889289  DQ889276  EF407445  EU155292  AY682777  EU155354  AY682761  DQ430811  DQ430812  DQ430813  DQ430814   48   16   23   12  23  49  3   38   10 14   DQ889282  AY683110  EU234063  EU155342  AY682783  AY683126  DQ249480  DQ889317  DQ889294  DQ889260  AY973849  AY973853  AY973848  AY973852  AY973851  DQ249472  DQ249474  DQ889300  P606  T294  T299  532920  533511  EU155238  EF407432  DQ889285  EU155379  DQ889304  DQ249476  DQ249479  AF511948  DQ889318 EU155272   DQ249481  EF407421  EF407420  EU155378  DQ889263  EU155273  EU155252  EF032888  EF032890  EF032889  DQ889281  DQ889254  AY683132  EF407440  EF407447  AY682778  AY683121  DQ249477  DQ249478  DQ889271  EF407424  EU155310  EU155290  AY683092  DQ889296  DQ889290  EF407418  EU155338  EU155288  AY682787  EU155216  EU155309  EU155320  AY683103  AY682755   36  3 DQ508484   DQ508477  AB057606  EU155376  EU155259  EU155307  AB189078  AB189079  EF407496  EF032891  EF032892  EF032893  EF032895  EF032894  AB189107  AB049087  AB049096  AB057682  AB109543  AB191333  EF608897  EF608896  EF608895   EF608792  EF608791   EF608790   EU155357  U45476   EF407492  EF407493   DQ249499  DQ249500   EU155363   AY835061   EU234062  EU155329  EU155255  EU155218  EU155235  EU155337  AY587844  EU155229  EU155263  DQ508480  EU155303  Z97730  EU155317  EU155306  EF407483  DQ345624  EU155304  EU155324  P237  P819 533655 P899 AY257445  AY257444  AY257466  DQ220864  DQ220871  L38368  AF516023  DQ220859  DQ220858  EF116047  L38375  L38358  EF116022  L38362  L38367  L38366  DQ220865  EF116046  DQ220875  DQ220915  DQ220911  DQ220922  DQ220816  AY957572  AY957574  DQ249521  DQ249520  DQ220841  DQ220842  DQ220820  DQ220837  DQ220838  DQ220840  DQ220839  D31985  DQ220854  DQ220869  DQ220872  DQ220867  DQ220868  DQ220856  DQ220857  AF516024  D31987  DQ220861   L38365  AF515996  AF515995   D31991  DQ220873   532978  AY172649  D31975   D84398  D31983   AY944664   AY944640  D31999  DQ220870  T300   AY172644  AY172647   D31981  AY172642  AY172643   D31997  AF516022  L38357  L38364   D31995  D31977   AF515980  AF515981  532441  DQ220874  AJ291280  DQ220862  532996  DQ220866  D31979  AF516025  AY944678  AY944682  D31993   AY944662   T301   28 Canada (Quebec) France (Seine Saint ¬Denis district) Argentina
The 3 rd column from the left shows the GenBank sequences that are most similar to each of our samples, and the 4 th column from the left exhibits the origin of the GenBank already deposited sequences HCV-2c sequences from the Argentine general population formed a heterogeneous group with a completely different pattern as compared with HCV-1b. The sequences clustered with GB sequences originated from HCV patients in Italy. Even the sequences reported from Southeastern France were obtained from Italians living in this region. Only one of the clustered GB sequences was documented in Estonia. Three of our 2c sequences were detected in Buenos Aires/C.A.B.A. and two in Tucumán (approximately 1200 km from C.A.B.A.).
When blasted with GB sequences, the single sequence assigned to HCV-2j clustered with those from Canada, France, and Spain, showing the high heterogeneity among the HCV-2j sequences analyzed.
Regarding the single HCV-3a local sequence, similarities were found with one sequence from Canada and another one from France, and with an additional group of five sequences reported in Argentina.
DISCUSSION
Here we report a very low prevalence of HCV infection (0.32%) in a large cohort of random volunteers from Argentina, contrasting with the 2% prevalence previously reported in studies based on selected populations in small communities, or even higher rates among highly vulnerable groups [12, 29] (Hepatitis C Argentinian Consensus, 2007). The observed prevalence is lower than that reported in neighboring countries, such as Brazil (1.5%), Uruguay (1%), and Chile (0.85%) [12] . The highest prevalence was detected in Buenos Aires province and C.A.B.A., both making up the region that received the greatest number of European immigrants, especially during the first half of the 20 th century (70.38% of all immigrants, 20.8% residing in C.A.B.A.; http://www.mininterior.gov.ar/poblacion/estadisticas.asp Censo2001). In this regard, recent data shows that at present most of the European immigrants from Italy and Spain are over 60-year-old (http://www. mininterior.gov.ar/provincias/archivos_prv25/6-%-0Perfil_Migratorio_de_la_Argentina.pdf).
The HCV isolates studied here did not form a close national cluster separate from the GB sequences. Interestingly, genetic divergence and phylogenetic analyses showed a different profile depending on the subtype analyzed. In this sense, the HCV-1a samples, detected from subjects residing in distantly placed cities/towns (hundreds of kilometers apart from each other) from three provinces, made up a highly homogeneous population, whereas the HCV-1b and HCV-2c samples were more heterogeneous, suggesting a different profile of epidemiological origin/transmission of infection for each subtype. The high homogeneity of subtype 1a and its similarity with sequences reported from United States suggest that HCV-1a was introduced in Argentina by a common infectious source from this geographic area. This finding agrees with the model of recent HCV genotype diversification in Central and South America [30] [31] [32] compared with other continents. HCV-1b isolates formed separate clusters that were most similar to European sequences, suggesting multiple focal transmission events, likely with independent geographical origins. Interestingly, the subject whose HCV isolate showed an HCV1b phylogenetic relationship with a Russian HCV-1b sequence stated such ethnicity. HCV-2c represents an important contribution to Argentinian HCV epidemiology (at least, 25% in this study), supporting previous observations (23%) [15] . Most of the 2c isolates clustered close to sequences reported from Italy and Southern France. In general, the 2c sequences deposited in GB represent a highly heterogeneous population with huge genetic diversity in Ghana, Guinea, Benin, and Burkina Faso in Africa [33] , suggesting that HCV-2c has long been present in human populations, especially in these parts of Africa, and that it spread to Egypt, Europe and elsewhere in the 20 th century [34] . It has been proposed that the introduction of HCV-2c in Italy was a consequence of close contacts between native Africans and soldiers and colonials during the colonial wars in 1882-1896 and 1911-1912 [35, 36] . A high prevalence of HCV-2c was observed among individuals in Italy [37] [38] [39] [40] and Southern France, all related with Italian immigrants [41] . Coincidentally, a substantial percentage of the Buenos Aires population descends from Italian immigrants that arrived in the 20 th century. Taken together, our results suggest that the introduction of HCV-2c in Argentina may have been the result of a multiple event, likely related to waves of Italian immigration. In this regard, it is worth mentioning that a high prevalence (approximately 50%) of this genotype has been reported among chronic HCV patients from Cór-doba province [19, 20, 29] , as compared with data from Buenos Aires and C.A.B.A. patients [15] and even higher rates (90%) from patients residing in Cruz del Eje, a small rural town located in the Northern region of Córdoba province, where HCV prevalence was reported to be 5% [29] . In contrast, the present study could not detect the circulation of such genotype from the general population studied in the city of Córdoba (encompassing the whole group from the homonymous province). Several hypothetical factors might have contributed to the observed discrepancy, among them, it seems worth mentioning: (1) the previously reported overall low prevalence of infection in the city of Córdoba [29] and in this study; (2) the lower contribution of HCV-2c to the total HCV genotype prevalence in such capital city located in the central region of the province, as compared with Cruz del Eje [20, 29] ; (3) the dissimilar nature of studied groups (patients versus general population), hence showing a dissimilar HCV infection prevalence, and consequently having lower probability to pick up HCV positive samples; and (4) the mean age ± SE of all the analyzed populations (49.77 ± 2.15 for patients from Córdoba and other locations of Córdoba Province (n = 26) [29] , 66.15 ± 1.52 years for patients from Cruz del Eje (n = 49) [29] , as compared with 37.1 ± 0.4 in this study (SD = 12.5; median age = 35 years; n = 668). However, the last mentioned factor failed to reach statis-tical significance when the one way analysis of variance was carried out (P = 0.1177).
The recorded HCV-3a sequence exhibited similarities with isolates from France and Canada and other Argentinian isolates, in concordance with a more recent, worldwide expansion of this subtype [22] . The HCV-2j sequence showed similarities with French, Canadian, and Spanish HCV sequences. No other genotypes (4, 5 or 6) were detected in the Argentine general population studied.
In conclusion, NS5B analysis allowed an accurate classification of subtypes and enabled to perform the study of the evolution and origin of HCV infection. Here, we report a very low prevalence of HCV in the Argentine general population (0.32%). Phylogenetic analysis suggests diverse profiles of epidemiological expansion of HCV in Argentina: HCV-1a might have occurred from a putative common source, whereas HCV-1b and HCV2c might have been introduced into the country following fluxes of immigration from other endemic areas, especially from Europe. The significantly high number of HCV-2c sequences compared to the reported data from neighboring countries may be the consequence of the high percentage of Italians migrating to Argentina from an area where such subtype was (and still is) highly prevalent. Argentina is a good example of how human practices, together with global expansion and human migration flows, have increased the HCV spread over the world. Adherence to standard universal precautions to avoid transmission should be strictly followed even in countries with a low prevalence of HCV.
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COMMENTS
Background
Hepatitis C virus (HCV) is a leading cause of chronic liver disease. HCV is distributed globally, affecting all countries with an estimated worldwide prevalence of 2.3% (approximately 160 million people) of the whole general population. Comparisons of HCV nucleotide sequences derived from individuals from different geographical regions revealed the circulation of at least six major HCV genotypes and more than 50 subtypes. Accurate HCV genotyping in chronically infected patients is crucial not only for epidemiological studies but also from a clinical standpoint, since the HCV genotype orientates the treatment strategy.
Research frontiers
Direct sequencing, also referred as "population" sequencing, is the gold standard for HCV genomic sequence analysis. The viral genome region(s) sequenced must be carefully chosen, because not all of them provide accurate typing and subtyping. Since genotyping methods based on the exclusive analysis of the 5′NCR may lead to up to 10% mistyped results, there is a need to extend the analysis to coding regions such as NS5B or core. In this regard, the knowledge of the implicated HCV genotype in each patient contributes to select the appropriate treatment. Those infected with HCV genotype 1 must be treated with a triple combination of pegylated interferon- (IFN-), ribavirin and either telaprevir or boceprevir, whereas patients infected with other genotypes must still be treated with pegylated IFN- and ribavirin alone. Moreover, HCV genotyping based on phylogenetic analysis, and -in case a representative sampling of a given (sub)genotype is obtained from an area -Monte Carlo Markov Chains Bayesian coalescent analysis may respectively lead to trace the origin and if such condition is met - the putative date of the Most Recent Common Ancestor of sequences.
Innovations and breakthroughs
